Clinical Trial

Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)

Study acronym: SSIHLVER
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-08-07; most recent amendment 2026-06-01.
Trial Details
NCT Number NCT06547138
Lead Sponsor Aesculap AG
Collaborators: B.Braun Surgical SA
Conditions Abdominal Aortic Aneurysm, Morbid Obesity
Enrollment 110 participants
Start Date 2026-09
Primary Completion 2027-10 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-02